|
RMTI | Rockwell Medical, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.51 |
| Leverage | 35.60% |
| Market Cap | $ 24.5m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -5.5m |
| Margin | -7.32% |
Rockwell Medical, Inc. is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with iron deficiency treatment and hemodialysis products and therapies in the United States and internationally. The company is headquartered in Wixom, Michigan.